Assisted Reproductive Technology (ART) Market Size Worth USD 50.32 Billion by 2027 | CAGR of 9.3%: Emergen Research

USA - English

• India - English

VANCOUVER, BC, Oct. 19, 2020 /PRNewswire/ -- The Global Assisted Reproductive Technology Market is projected to be worth USD 50.32 Billion by 2027, according to a new report by Emergen Research. The market for assisted reproductive technology (ART) is experiencing rapid growth attributed to the surging popularity of in-vitro fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination-intrauterine (AI-IUI), among other technologies. The growing prevalence of ovulation problems, a common cause of infertility in women with irregular or no periods, is a key factor boosting assisted reproductive technology market growth and accounts for around 25.0% of infertility cases in women across the globe.

A lack of awareness pertaining to fertility in people of the young generation and women opting for fertility treatments could increase fertility duration and, in due course, may need in-vitro fertilization, thereby fueling the demand for assisted reproductive technology. Infertility is a multi-faceted issue involving social, cultural, and economic implications, which may reach threatening extents in nations with having problems with demographics. According to statistics published by WHO, about 8.0-10.0% of couples are suffering from a certain type of infertility issue.

A significant cause of infertility in the worldwide population is sexually transmitted diseases (STDs), predominantly gonorrhea and chlamydia, which, in turn, would boost the growth of the assisted reproductive technology market. It may cause damage or scarring in the fallopian tubes and blockage and scarring of the reproductive structures (e.g., ejaculatory ducts), resulting in infertility.

Request free sample of this research report at: https://www.emergenresearch.com/request-sample/165

Key Highlights from The Report

• In June 2020, Ferring Pharmaceuticals made an announcement about signing a two-year agreement with Igenomix for researching innovative disease mechanisms and target discovery in conditions associated with infertility and pregnancy, such as preeclampsia, for developing groundbreaking diagnostic and therapeutic approaches in catering to unmet demand.
• Frozen non-donor eggs are projected to grow at the fastest rate in the period 2020-2027, owing to their established reliability and a higher success rate for pregnancy.
• Artificial Insemination-Intrauterine doesn't require the removal of eggs from the body, and hence the procedure is far less invasive for the women who would conceive. Moreover, the process is cost-effective compared to IVF, as it doesn't require egg extraction/laboratory monitoring.
• Factors such as well-resourced operating & surgical rooms, the presence of highly skilled healthcare professionals, higher purchasing power, and enhanced health coverage for healthcare services from various plans for private and group insurance, among others, are driving the demand for assisted reproductive technology in hospitals. However, a decreased adoption of the latest and innovative up-gradation is responsible for a lower market share.
• Europe, led by France, Germany, and the U.K., contributed to the largest assisted reproductive technology market share in 2019 attributed to growing novelties in clinical practice and improved fertility treatment access in the region. Also, the region is the first to remove the 'experimental' tag on cryopreservation of eggs.
• Key participants include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd., among others.

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/assistive-reproductive-technology-market

Emergen Research has segmented the Global Assisted Reproductive Technology (ART) Market on the basis of procedure, technology, end-user, and region:

Procedure Outlook (Revenue, USD Billion; 2017-2027)

• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor
• Egg/Embryo Banking

Technology Outlook (Revenue, USD Billion; 2017-2027)

• In-Vitro Fertilization (IVF)
  1. In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
  2. In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
• Artificial Insemination-Intrauterine (AI-IUI)
• Frozen Embryo Transfer (FET)
• Others

Oder Now: https://www.emergenresearch.com/select-license/165

End-User Outlook (Revenue, USD Billion; 2017-2027)

• Hospitals
• Fertility Clinics
• Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. U.K.
  3. France
  4. BENELUX
  5. Rest of Europe
• Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• Middle East & Africa
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

Find more similar research insights by Emergen Research:

Wound Cleanser Products Market By Product Type (Wetting Agents, Antiseptics, Moisturizers, Others), By Form Type (Sprays, Solutions, Wipes, Foams, Others), By End User (Hospitals, Ambulatory Surgery Centers, Pharmacies and Clinics, Homecare Settings) and By Regions Forecasts to 2027

Carrier Screening Market By Medical Conditions (Pulmonary, Hematological and Neurological Disorders, Others), By Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), By End User (Hospitals, Reference Laboratories, Physician Offices and Clinics, Others) and By Regions Forecasts to 2027

Big Data in Healthcare Market By Component (Software, Services), By Deployment (On-Premises, Cloud), By Analytics Type (Predictive Analytics, Descriptive Analytics), By Application (Clinical Analytics, Financial Analytics), By End User (Hospitals and Clinics), and By Region, Forecasts to 2027

Photoacoustic Imaging Market By Product (Imaging Systems, Lasers, Transducers, Contrast Agents, Software), By Application (Oncology, Cardiology, Neurology, Hematology, Others), By End User (Research Institutions, Hospitals & Clinics) and By Regions Forecasts to 2027

Cancer Imaging Systems Market By Imaging Systems, By Application, By End-Users, Forecasts to 2027

About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]

Read full Press Release at: https://www.emergenresearch.com/press-release/global-assisted-reproductive-technology-market

SOURCE Emergen Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED